Does BROLUCIZUMAB Cause Vasculitis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Vasculitis have been filed in association with BROLUCIZUMAB (BEOVU). This represents 0.7% of all adverse event reports for BROLUCIZUMAB.
5
Reports of Vasculitis with BROLUCIZUMAB
0.7%
of all BROLUCIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Vasculitis From BROLUCIZUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Vasculitis Listed in the Official Label?
Yes, Vasculitis is listed as a known adverse reaction in the official FDA drug label for BROLUCIZUMAB.
What Other Side Effects Does BROLUCIZUMAB Cause?
Visual impairment (116)
Vision blurred (106)
Eye pain (81)
Vitreous floaters (74)
Vitritis (65)
Ocular hyperaemia (62)
Off label use (62)
Subretinal fluid (62)
Retinal vasculitis (52)
Eye inflammation (50)
What Other Drugs Cause Vasculitis?
PREDNISONE (754)
APIXABAN (645)
RITUXIMAB (600)
ALBUTEROL (519)
METHOTREXATE (494)
LEVOTHYROXINE (475)
HYDROCHLOROTHIAZIDE (471)
ADALIMUMAB (461)
CANDESARTAN (434)
MEPOLIZUMAB (430)
Which BROLUCIZUMAB Alternatives Have Lower Vasculitis Risk?
BROLUCIZUMAB vs BROLUCIZUMAB-DBLL
BROLUCIZUMAB vs BROMAZEPAM
BROLUCIZUMAB vs BROMFENAC
BROLUCIZUMAB vs BROMHEXINE
BROLUCIZUMAB vs BROMOCRIPTINE